Effect of Glycemic Index on Physical Capacity in Runners

February 20, 2017 updated by: Krzysztof Durkalec-Michalski, PhD, Poznan University of Life Sciences

Effects of Low and Versus Moderate Glycemic Index Diets on Physical Capacity and Body Composition in Endurance- Trained Runners

The purpose of the present study was to assess the influence of low vs moderate glycemic index of a 3-week diet on aerobic capacity, endurance performance and body mass and composition in endurance-trained athletes in a randomized, controlled crossover trial.

Study Overview

Detailed Description

The effect of glycemic index of pre-exercise meal on endurance capacity and performance has been widely investigated. However, little is known about the adaptations to longer dietary interventions with different glycemic index and their influence on aerobic capacity and body composition in runners. Therefore, the purpose of this study was the assessment of the influence of low GI vs moderate GI of a 3-week diet on aerobic capacity, endurance performance and body mass and composition in endurance-trained athletes in a randomised, controlled crossover trial.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wielkopolska
      • Poznan, Wielkopolska, Poland, 60-624
        • Poznan University of Life Sciences, ul.Wojska Polskiego 31

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 37 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • written consent to participate,
  • male and female,
  • a current medical clearance to practice sports,
  • training experience: at least 3 years,
  • minimum of 4 workout sessions a week lasting at least 1.5-2 hours/day,
  • age: 17 - 37 years.

Exclusion Criteria:

  • current injury,
  • any health-related contraindication,
  • declared general feeling of being unwell,
  • unwilling to follow the study protocol,
  • smoking, illicit drug use, alcohol consumption greater than 1-2 drinks/week, dietary supplements use less than 3 weeks before the study,
  • females- being pregnant or planning to become pregnant during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low Glycemic Index Diet

Group consuming low glycemic index diet. Calculated glycemic index of daily diet was lower than 40. Carbohydrate- containing foods included whole rye bread, pumpernickel bread, whole oats, wheat brans, brown rice, buckwheat, vegetables (besides corn, cooked carrots, potatoes and pumpkin) and fruit such as apples, pears, grapefruits, tangerines, prunes, dried apricots and unripe bananas.

Interventions:

The experimental procedure for each participant included a 3-week low glycemic index diet. Between the 3-week low and moderate glycemic index diets or a moderate and low glycemic index treatment, a 14-day washout period was introduced.

Experimental: Moderate Glycemic Index Diet

Group consuming moderate glycemic index diet. Calculated glycemic index of diet was higher than 60. Carbohydrate- containing foods included wheat bread, wheat rolls, potatoes, instant oats, cornflakes, white rice, millet, boiled carrots and fruit (ripe bananas, grapes, raisins, dates, cranberry, honey and high sugar jams)

Interventions:

The experimental procedure for each participant included a 3-week moderate glycemic index diet. Between the 3-week low and moderate glycemic index diets or a moderate and low glycemic index treatment, a 14-day washout period was introduced.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in aerobic capacity following low glycemic index diet
Time Frame: Baseline and after 3 weeks
Baseline and after 3 weeks
Changes in aerobic capacity following moderate glycemic index diet
Time Frame: Baseline and after 3 weeks
Baseline and after 3 weeks
Changes in performance in 12-min running test following low glycemic index diet
Time Frame: Baseline and after 3 weeks
Baseline and after 3 weeks
Changes in performance in 12-min running test following moderate glycemic index diet
Time Frame: Baseline and after 3 weeks
Baseline and after 3 weeks
Changes in fat mass and fat free mass following low glycemic index diet
Time Frame: Baseline and after 3 weeks
Fat mass (kg) and fat free mass (kg) analysis
Baseline and after 3 weeks
Changes in fat mass and fat free mass following moderate glycemic index diet
Time Frame: Baseline and after 3 weeks
Fat mass (kg) and fat free mass (kg) analysis
Baseline and after 3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Statistical evaluation of the significance of differences between the changes in aerobic capacity indices
Time Frame: 1 year
1 year
Statistical evaluation of the significance of differences between the changes in performance in 12-min running test
Time Frame: 1 year
1 year
Statistical evaluation of the significance of differences between the changes in fat mass and fat free mass
Time Frame: 1 year
Fat mass (kg) and fat free mass (kg)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jan Jeszka, Professor, Department of Hygiene and Human Nutrition, Poznan University of Life Sciences, Poznan, Poland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

February 6, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

February 14, 2017

First Submitted That Met QC Criteria

February 20, 2017

First Posted (Actual)

February 23, 2017

Study Record Updates

Last Update Posted (Actual)

February 23, 2017

Last Update Submitted That Met QC Criteria

February 20, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

Shared data will be exclusively related to the level recorded indicators (body composition, aerobic capacity, performance in 12-min running test), without personal data. Depending on the requirements of the journal, the data obtained will be attached to scientific publications, deposited in a public repository or provided by principal investigator when requested.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glycemic Index

Clinical Trials on Dietary Intervention: Low vs. moderate glycemic index

3
Subscribe